Integration of multiple lineage measurements from the same cell reconstructs parallel tumor evolution
Lennart Kester,
Buys de Barbanson,
Anna Lyubimova,
Li-Ting Chen,
Valérie van der Schrier,
Anna Alemany,
Dylan Mooijman,
Josi Peterson-Maduro,
Jarno Drost,
Jeroen de Ridder,
Alexander van Oudenaarden
Affiliations
Lennart Kester
Oncode Institute, Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences), 3584 CT Utrecht, the Netherlands
Buys de Barbanson
Oncode Institute, Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences), 3584 CT Utrecht, the Netherlands; Oncode Institute, Center for Molecular Medicine, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands
Anna Lyubimova
Oncode Institute, Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences), 3584 CT Utrecht, the Netherlands
Li-Ting Chen
Oncode Institute, Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences), 3584 CT Utrecht, the Netherlands; Oncode Institute, Center for Molecular Medicine, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands
Valérie van der Schrier
Oncode Institute, Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences), 3584 CT Utrecht, the Netherlands
Anna Alemany
Oncode Institute, Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences), 3584 CT Utrecht, the Netherlands
Dylan Mooijman
Oncode Institute, Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences), 3584 CT Utrecht, the Netherlands
Josi Peterson-Maduro
Oncode Institute, Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences), 3584 CT Utrecht, the Netherlands
Jarno Drost
Oncode Institute, Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, the Netherlands
Jeroen de Ridder
Oncode Institute, Center for Molecular Medicine, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands; Corresponding author
Alexander van Oudenaarden
Oncode Institute, Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences), 3584 CT Utrecht, the Netherlands; Corresponding author
Summary: Organoid evolution models complemented with integrated single-cell sequencing technology provide a powerful platform to characterize intra-tumor heterogeneity (ITH) and tumor evolution. Here, we conduct a parallel evolution experiment to mimic the tumor evolution process by evolving a colon cancer organoid model over 100 generations, spanning 6 months in time. We use single-cell whole-genome sequencing (WGS) in combination with viral lineage tracing at 12 time points to simultaneously monitor clone size, CNV states, SNV states, and viral lineage barcodes for 1,641 single cells. We integrate these measurements to construct clonal evolution trees with high resolution. We characterize the order of events in which chromosomal aberrations occur and identify aberrations that recur multiple times within the same tumor sub-population. We observe recurrent sequential loss of chromosome 4 after loss of chromosome 18 in four unique tumor clones. SNVs and CNVs identified in our organoid experiments are also frequently reported in colorectal carcinoma samples, and out of 334 patients with chromosome 18 loss in a Memorial Sloan Kettering colorectal cancer cohort, 99 (29.6%) also harbor chromosome 4 loss. Our study reconstructs tumor evolution in a colon cancer organoid model at high resolution, demonstrating an approach to identify potentially clinically relevant genomic aberrations in tumor evolution.